A Clinical Study of AK139 in Healthy Subjects

Monitor for a minimum of 24 hours to assess whether the safety and tolerability are acceptable according to the investigator.

The study will use dose escalation scheme. Before proceeding to randomize the next group of subjects, the safety data from all subjects in the previous dose group must be reviewed and confirmed.